291 related articles for article (PubMed ID: 7893238)
1. Assertive community treatment for the seriously mentally ill in suburban Sydney: a programme description and evaluation.
Hambridge JA; Rosen A
Aust N Z J Psychiatry; 1994 Sep; 28(3):438-45. PubMed ID: 7893238
[TBL] [Abstract][Full Text] [Related]
2. Assertive community treatment in the Netherlands: a randomized controlled trial.
Sytema S; Wunderink L; Bloemers W; Roorda L; Wiersma D
Acta Psychiatr Scand; 2007 Aug; 116(2):105-12. PubMed ID: 17650271
[TBL] [Abstract][Full Text] [Related]
3. Impact of assertive community treatment on homeless persons with co-occurring severe psychiatric and substance use disorders.
Meisler N; Blankertz L; Santos AB; McKay C
Community Ment Health J; 1997 Apr; 33(2):113-22. PubMed ID: 9145253
[TBL] [Abstract][Full Text] [Related]
4. Service utilization and costs of care for severely mentally ill clients in an intensive case management program.
Quinlivan R; Hough R; Crowell A; Beach C; Hofstetter R; Kenworthy K
Psychiatr Serv; 1995 Apr; 46(4):365-71. PubMed ID: 7788458
[TBL] [Abstract][Full Text] [Related]
5. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
Jerrell JM; Ridgely MS
Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcome in patients receiving assertive community treatment.
Kortrijk HE; Mulder CL; Roosenschoon BJ; Wiersma D
Community Ment Health J; 2010 Aug; 46(4):330-6. PubMed ID: 19847646
[TBL] [Abstract][Full Text] [Related]
7. Do community mental health teams caring for severely mentally ill patients adjust treatments and services based on patients' antisocial or criminal behaviours?
Hodgins S; Cree A; Khalid F; Patel K; Sainz-Fuertes R; Shortt M; Mak T; Riaz M
Eur Psychiatry; 2009 Sep; 24(6):373-9. PubMed ID: 19726165
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
Horsfall J; Cleary M; Hunt GE; Walter G
Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
[TBL] [Abstract][Full Text] [Related]
9. [Study of the impact of an assertive community program on the families of patients with severe mental disorders].
Huguelet P; Koellner V; Boulguy S; Nagalingum K; Amani S; Borras L; Perroud N
Encephale; 2012 Jun; 38(3):201-10. PubMed ID: 22726408
[TBL] [Abstract][Full Text] [Related]
10. The COSTAR programme. 1: Improving social networks of the long-term mentally ill.
Thornicroft G; Breakey WR
Br J Psychiatry; 1991 Aug; 159():245-9. PubMed ID: 1773241
[TBL] [Abstract][Full Text] [Related]
11. Steven: testing the limits of assertive community treatment.
Mays D
New Dir Ment Health Serv; 1995; (65):37-46; discussion 47-51. PubMed ID: 7753007
[No Abstract] [Full Text] [Related]
12. Three-year outcome of treatment in an early psychosis program.
Addington J; Addington D
Can J Psychiatry; 2009 Sep; 54(9):626-30. PubMed ID: 19751551
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and usefulness of training assertive community treatment team in cognitive behavioral therapy.
Pinninti NR; Fisher J; Thompson K; Steer R
Community Ment Health J; 2010 Aug; 46(4):337-41. PubMed ID: 19957105
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric and social reasons for frequent rehospitalization.
Kent S; Yellowlees P
Hosp Community Psychiatry; 1994 Apr; 45(4):347-50. PubMed ID: 8020919
[TBL] [Abstract][Full Text] [Related]
16. Re: Using global assessment of functioning to evaluate an assertive community treatment program.
Malla A
Can J Psychiatry; 2001 Dec; 46(10):986-7. PubMed ID: 11816322
[No Abstract] [Full Text] [Related]
17. Comparison of long-term outcome of schizophrenic, affective and schizoaffective disorders.
Marneros A; Deister A; Rohde A
Br J Psychiatry Suppl; 1992 Oct; (18):44-51. PubMed ID: 1389041
[No Abstract] [Full Text] [Related]
18. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF).
Jones SH; Thornicroft G; Coffey M; Dunn G
Br J Psychiatry; 1995 May; 166(5):654-9. PubMed ID: 7620753
[TBL] [Abstract][Full Text] [Related]
19. Borderline personality disorder: a challenge for mental health services.
Clarke M; Hafner RJ; Holme G
Aust N Z J Psychiatry; 1995 Sep; 29(3):409-14. PubMed ID: 8573043
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness.
McDonell MG; Srebnik D; Angelo F; McPherson S; Lowe JM; Sugar A; Short RA; Roll JM; Ries RK
Am J Psychiatry; 2013 Jan; 170(1):94-101. PubMed ID: 23138961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
